The emergence of data from clinical trials of biologics, the approval of new biologics, and
our improved understanding of psoriasis pathogenesis have increased the therapeutic …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …

There is increasing interest in the association between psoriasis and non-alcoholic fatty liver
disease (NAFLD), which is a prevalent liver disease characterized by excessive fat storage …

Psoriasis is a chronic immune-mediated skin and joint disease, with a plethora of
comorbidities, characterized by a certain genetic predisposition, and a complex …

Despite the increasing use of protoplasts in plant biotechnology research, shoot
regeneration from protoplasts remains challenging. In this study, we investigated the factors …

Background Psoriasis patients carry an increased risk for associated comorbidities.
Dermatologists have to be aware of the effects of systemic treatments not only on psoriasis …

This review updates current knowledge regarding the risk of viral infections, including
COVID-19, in patients treated with cyclosporine. We also shortly refer to bacterial infections …

Abstract Background and Objective Biologics for psoriasis, especially anti-tumor necrosis
factor-α therapies, may reactivate hepatitis B virus (HBV) or hepatitis C virus (HCV) …

Objective To evaluate the safety of secukinumab (SEC) in the treatment of patients with axial
spondyloarthritis (axSpA) and concurrent hepatitis B virus (HBV) infection or latent …